Table 1 Demographic and clinical characteristics of QL patients
| Â | QL Study | Main study | ||||
|---|---|---|---|---|---|---|
| Â | High dose N =198 | Conventional N =192 | N =605 | |||
Age mean, 95% CI | 45 | (22, 60) | 46 | (25, 63) | 46 | (2, 64) |
Menopausal status | N | % of known | N | % of known | N | % of known |
 Premenopausal | 132 | 67 | 121 | 63 | 400 | 66 |
 Perimenopausal | 23 | 12 | 19 | 10 | 62 | 10 |
 Postmenopausal | 42 | 21 | 51 | 27 | 138 | 23 |
 Missing | 1 |  | 1 |  | 5 |  |
Radiation to the breast | ||||||
 Yes | 179 | 95 | 179 | 95 | 547 | 95 |
 No | 10 | 5 | 10 | 5 | 30 | 5 |
 Missing | 9 |  | 3 |  | 28 |  |
Radiation to the axilla | ||||||
 Yes | 39 | 21 | 46 | 24 | 156 | 27 |
 No | 150 | 79 | 143 | 76 | 421 | 73 |
 Missing | 9 |  | 3 |  | 28 |  |
Tamoxifen | ||||||
 Yes | 152 | 80 | 150 | 79 | 465 | 81 |
 No | 36 | 20 | 39 | 21 | 110 | 19 |
 Missing | 10 |  | 3 |  | 30 |  |